Our results showed that PTER-ITC activated PPARγ expression in a dose-dependent manner, followed by downregulation of its anti-apoptotic genes (Bcl-2 and survivin) to induce noteworthy levels of apoptosis in hormone-dependent (MCF-7) and -independent (MDA-MB-231) breast cancer cells. This evidence concerns the gene BCL2 and breast carcinoma.